| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemolysis | D006461 | 131 associated lipids |
| Uremia | D014511 | 33 associated lipids |
| Colitis, Ulcerative | D003093 | 24 associated lipids |
| Stomach Ulcer | D013276 | 75 associated lipids |
| Kidney Failure, Chronic | D007676 | 51 associated lipids |
| Diabetes Mellitus | D003920 | 90 associated lipids |
| Hypoxia | D000860 | 23 associated lipids |
| Arrhythmias, Cardiac | D001145 | 42 associated lipids |
| Hypercalcemia | D006934 | 13 associated lipids |
| Neovascularization, Pathologic | D009389 | 39 associated lipids |
| Tumor Virus Infections | D014412 | 8 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Dermatitis, Contact | D003877 | 59 associated lipids |
| Pain | D010146 | 64 associated lipids |
| Lupus Erythematosus, Systemic | D008180 | 43 associated lipids |
| Lung Diseases | D008171 | 37 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Pulmonary Fibrosis | D011658 | 24 associated lipids |
| Wounds and Injuries | D014947 | 20 associated lipids |
| Pleurisy | D010998 | 20 associated lipids |
Platelet activating factor
Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.
Cross Reference
Introduction
To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Platelet activating factor?
Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Platelet activating factor
PubChem Associated disorders and diseases
What pathways are associated with Platelet activating factor
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Platelet activating factor?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Platelet activating factor?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Platelet activating factor?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Platelet activating factor?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Platelet activating factor?
Knock-out
Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).
Mouse Model
Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).
Transgenic Model
Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Platelet activating factor
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Lemieux C et al. | Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses. | 2005 | Blood | pmid:15498854 |
| Bellone G et al. | Bone marrow stroma-derived prolactin is involved in basal and platelet-activating factor-stimulated in vitro erythropoiesis. | 1997 | Blood | pmid:9207433 |
| Matsumoto K et al. | Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. | 1995 | Blood | pmid:7543306 |
| Dejana E et al. | Modulation of endothelial cell functions by different molecular species of interleukin 1. | 1987 | Blood | pmid:3542082 |
| Fulkerson PC et al. | CXCL9 inhibits eosinophil responses by a CCR3- and Rac2-dependent mechanism. | 2005 | Blood | pmid:15802529 |
| Naccache PH et al. | Selective inhibition of human neutrophil functional responsiveness by erbstatin, an inhibitor of tyrosine protein kinase. | 1990 | Blood | pmid:2173635 |
| Hoffman DR et al. | Cytotoxicity of platelet activating factor and related alkyl-phospholipid analogs in human leukemia cells, polymorphonuclear neutrophils, and skin fibroblasts. | 1984 | Blood | pmid:6696992 |
| Roos D et al. | A novel syndrome of severe neutrophil dysfunction: unresponsiveness confined to chemotaxin-induced functions. | 1993 | Blood | pmid:8098232 |
| Sehmi R et al. | Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. | 1992 | Blood | pmid:1316789 |
| Warringa RA et al. | In vivo priming of platelet-activating factor-induced eosinophil chemotaxis in allergic asthmatic individuals. | 1992 | Blood | pmid:1558975 |
| Camussi G et al. | Release of platelet-activating factor from HL-60 human leukemic cells following macrophage-like differentiation. | 1982 | Blood | pmid:6947829 |
| Gabbeta J et al. | Abnormal inside-out signal transduction-dependent activation of glycoprotein IIb-IIIa in a patient with impaired pleckstrin phosphorylation. | 1996 | Blood | pmid:8608226 |
| Koenderman L et al. | Granulocyte-macrophage colony-stimulating factor induces sequential activation and deactivation of binding via a low-affinity IgG Fc receptor, hFc gamma RII, on human eosinophils. | 1993 | Blood | pmid:8481520 |
| Flores NA et al. | Platelet-mediated alterations in cardiac cellular electrophysiology. | 1991 | Blood Coagul. Fibrinolysis | pmid:1893068 |
| Smith IL and Smith EA | Inhibition of PAF-induced activation of human platelets by verapamil. | 1992 | Blood Coagul. Fibrinolysis | pmid:1336985 |
| Jarvis GE and Evans RJ | Platelet-activating factor and not thromboxane A2 is an important mediator of endotoxin-induced platelet aggregation in equine heparinised whole blood in vitro. | 1996 | Blood Coagul. Fibrinolysis | pmid:8735817 |
| Nakonechnicov S et al. | Platelet aggregation in patients with primary pulmonary hypertension. | 1996 | Blood Coagul. Fibrinolysis | pmid:8735825 |
| Sanderson HM et al. | Studies on the effects of agonists and antagonists on platelet shape change and platelet aggregation in whole blood. | 1996 | Blood Coagul. Fibrinolysis | pmid:8735830 |
| Bkaily G et al. | Modulation of cardiac cell Ca2+ currents by PAF. | 1996 | Blood Press Suppl | pmid:8973773 |
| Stahl GL and Lefer AM | Heterogeneity of vascular smooth muscle responsiveness to lipid vasoactive mediators. | 1987 | Blood Vessels | pmid:3567363 |
| Giers G et al. | Failure of the platelet-activating-factor antagonist WEB 2086 BS for treatment of chronic autoimmune thrombocytopenia. | 1990 | Blut | pmid:2386844 |
| Bull HA and Machin SJ | The haemostatic function of the vascular endothelial cell. | 1987 | Blut | pmid:3111566 |
| Parrill AL et al. | Computational identification and experimental characterization of substrate binding determinants of nucleotide pyrophosphatase/phosphodiesterase 7. | 2011 | BMC Biochem. | pmid:22177013 |
| Tung JP et al. | Respiratory burst function of ovine neutrophils. | 2009 | BMC Immunol. | pmid:19422720 |
| Wislet-Gendebien S et al. | Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors. | 2008 | BMC Neurosci | pmid:18808659 |
| Huang JF et al. | Protective effect of high concentration of BN52021 on retinal contusion in cat eyes. | 2015 | BMC Ophthalmol | pmid:25956877 |
| Grotta MB et al. | Obesity increases eosinophil activity in asthmatic children and adolescents. | 2013 | BMC Pulm Med | pmid:23773659 |
| Ghezzi E | Autacoids and some mediators in allergic and non allergic forms. | 1986 | Boll Ist Sieroter Milan | pmid:2877678 |
| Wucherpfennig AL et al. | Platelet activating factor increases intracellular calcium in isolated osteoclasts but does not modify bone resorption. | 1993 | Bone | pmid:8442997 |
| Siminiak T et al. | Plasma mediated neutrophil stimulation during coronary angioplasty: autocrine effect of platelet activating factor. | 1995 | Br Heart J | pmid:8541167 |
| Biffl WL and Moore EE | Splanchnic ischaemia/reperfusion and multiple organ failure. | 1996 | Br J Anaesth | pmid:8703631 |
| Bellamy MC et al. | Changes in inflammatory mediators during orthotopic liver transplantation. | 1997 | Br J Anaesth | pmid:9389852 |
| Taylor ML et al. | The differential effect of aspirin on human platelet activation in aspirin-sensitive asthmatics and normal subjects. | 1993 | Br J Clin Pharmacol | pmid:8471399 |
| Nieminen MM et al. | Inhaled budesonide fails to inhibit the PAF-induced increase in plasma leukotriene B4 in man. | 1992 | Br J Clin Pharmacol | pmid:1327049 |
| Sciberras DG et al. | The role of histamine in the acute inflammatory responses to intradermal platelet activating factor. | 1991 | Br J Clin Pharmacol | pmid:1679658 |
| Wilkens JH et al. | Effects of a PAF-antagonist (BN 52063) on bronchoconstriction and platelet activation during exercise induced asthma. | 1990 | Br J Clin Pharmacol | pmid:2297463 |
| Barradas MA et al. | The effect of fenfluramine on collagen-induced platelet aggregation in vitro. | 1983 | Br J Clin Pharmacol | pmid:6626443 |
| Roberts NM et al. | Effect of a PAF antagonist, BN52063, on PAF-induced bronchoconstriction in normal subjects. | 1988 | Br J Clin Pharmacol | pmid:3203062 |
| Taylor ML et al. | The effects of varying doses of aspirin on human platelet activation induced by PAF, collagen and arachidonic acid. | 1992 | Br J Clin Pharmacol | pmid:1540486 |
| Arnout J et al. | Effectiveness and tolerability of CV-3988, a selective PAF antagonist, after intravenous administration to man. | 1988 | Br J Clin Pharmacol | pmid:3289599 |
| Sciberras DG et al. | Inflammatory responses to intradermal injection of platelet activating factor, histamine and prostaglandin E2 in healthy volunteers: a double blind investigation. | 1987 | Br J Clin Pharmacol | pmid:2449904 |
| Ritter JM | Novel targets and regulatory ordeal by QT interval. | 2010 | Br J Clin Pharmacol | pmid:20406216 |
| Donado E et al. | No cardiac effects of therapeutic and supratherapeutic doses of rupatadine: results from a 'thorough QT/QTc study' performed according to ICH guidelines. | 2010 | Br J Clin Pharmacol | pmid:20406224 |
| Page CP | The role of platelet activating factor in allergic respiratory disease. | 1990 | Br J Clin Pharmacol | pmid:2268512 |
| Barr RM et al. | Platelet activating factor, lyso-platelet activating factor and arachidonic acid release in normal human skin and the influence of topical steroid treatment. | 1993 | Br J Clin Pharmacol | pmid:8329291 |
| Lellouch-Tubiana A et al. | Ultrastructural evidence for extravascular platelet recruitment in the lung upon intravenous injection of platelet-activating factor (PAF-acether) to guinea-pigs. | 1985 | Br J Exp Pathol | pmid:3890915 |
| Pirotzky E et al. | Protection of platelet-activating factor-induced acute renal failure by BN 52021. | 1988 | Br J Exp Pathol | pmid:3377967 |
| Barnes PJ | Mediators and asthma. | 1985 | Br J Hosp Med | pmid:3936563 |
| Biffl WL et al. | Gut-derived mediators of multiple organ failure: platelet-activating factor and interleukin-6. | 1995 Aug 16-Sep 5 | Br J Hosp Med | pmid:7582362 |
| Gordon T et al. | Airway oedema and obstruction in guinea pigs exposed to inhaled endotoxin. | 1991 | Br J Ind Med | pmid:1911406 |
| Morris C et al. | Transfer and metabolism of platelet-activating factor by fetal membranes, amnion and chorio-decidua. | 1992 | Br J Obstet Gynaecol | pmid:1450138 |
| Norris LA et al. | Whole blood platelet aggregation in moderate and severe pre-eclampsia. | 1993 | Br J Obstet Gynaecol | pmid:8369255 |
| Beuk RJ et al. | Leucocyte and platelet adhesion in different layers of the small bowel during experimental total warm ischaemia and reperfusion. | 2008 | Br J Surg | pmid:18720462 |
| Davies MG and Hagen PO | Systemic inflammatory response syndrome. | 1997 | Br J Surg | pmid:9240130 |
| Hashikura Y et al. | Effect of platelet-activating factor on cold-preserved liver grafts. | 1994 | Br J Surg | pmid:7827938 |
| Formela LJ et al. | Amelioration of experimental acute pancreatitis with a potent platelet-activating factor antagonist. | 1994 | Br J Surg | pmid:7827939 |
| Wang X et al. | Inhibition of platelet-activating factor, intercellular adhesion molecule 1 and platelet endothelial cell adhesion molecule 1 reduces experimental pancreatitis-associated gut endothelial barrier dysfunction. | 1999 | Br J Surg | pmid:10201790 |
| Botha AJ et al. | Sequential systemic platelet-activating factor and interleukin 8 primes neutrophils in patients with trauma at risk of multiple organ failure. | 1996 | Br J Surg | pmid:8944457 |
| Kingsnorth AN et al. | Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis. | 1995 | Br J Surg | pmid:7489182 |
| Lohmeyer M and Workman P | Growth arrest vs direct cytotoxicity and the importance of molecular structure for the in vitro anti-tumour activity of ether lipids. | 1995 | Br. J. Cancer | pmid:7640206 |
| Andrade SP et al. | Effects of tumour cells on angiogenesis and vasoconstrictor responses in sponge implants in mice. | 1992 | Br. J. Cancer | pmid:1384642 |
| Xu B et al. | Effects of platelet-activating factor and its differential regulation by androgens and steroid hormones in prostate cancers. | 2013 | Br. J. Cancer | pmid:23949154 |
| Cellai C et al. | Growth inhibition and differentiation of human breast cancer cells by the PAFR antagonist WEB-2086. | 2006 | Br. J. Cancer | pmid:16721373 |
| Brunton VG and Workman P | In vitro antitumour activity of the novel imidazoisoquinoline SDZ 62-434. | 1993 | Br. J. Cancer | pmid:8388233 |
| Izaki S et al. | Platelet-activating factor and arachidonic acid metabolites in psoriatic inflammation. | 1996 | Br. J. Dermatol. | pmid:8763425 |
| Michel L and Dubertret L | A simple method for studying chemotaxis, vascular permeability and histological modifications induced by mediators of inflammation in vivo in man. | 1985 | Br. J. Dermatol. | pmid:2990519 |
| Church MK | Efficacy and tolerability of rupatadine at four times the recommended dose against histamine- and platelet-activating factor-induced flare responses and ex vivo platelet aggregation in healthy males. | 2010 | Br. J. Dermatol. | pmid:20819087 |
| Greaves MW and Judge MR | Platelet activating factor in psoriasis. | 1997 | Br. J. Dermatol. | pmid:9115938 |
| Csatò M and Czarnetzki BM | Effect of BN 52021, a platelet activating factor antagonist, on experimental murine contact dermatitis. | 1988 | Br. J. Dermatol. | pmid:3377969 |
| Archer CB et al. | Inflammatory cell accumulation in response to intracutaneous Paf-acether: a mediator of acute and persistent inflammation? | 1985 | Br. J. Dermatol. | pmid:4015978 |
| Morley J et al. | The role of circulating cells in skin reactions. | 1985 | Br. J. Dermatol. | pmid:4015983 |
| Pirotzky E et al. | A role for Paf-acether (platelet-activating factor) in acute skin inflammation? | 1985 | Br. J. Dermatol. | pmid:4015984 |
| Archer CB et al. | Accumulation of inflammatory cells in response to intracutaneous platelet activating factor (Paf-acether) in man. | 1985 | Br. J. Dermatol. | pmid:3978036 |
| Kemény L et al. | Effect of BN 52021, a platelet activating factor antagonist, on dithranol-induced inflammation. | 1990 | Br. J. Dermatol. | pmid:2337521 |
| Archer CB et al. | Inflammatory characteristics of platelet activating factor (PAF-acether) in human skin. | 1984 | Br. J. Dermatol. | pmid:6581831 |
| Ormerod AD et al. | Effects of alprazolam on platelet activating factor-induced wealing. | 1989 | Br. J. Dermatol. | pmid:2803963 |
| White JG et al. | Influence of combined thrombin stimulation, surface activation, and receptor occupancy on organization of GPIb/IX receptors on human platelets. | 1994 | Br. J. Haematol. | pmid:7803236 |
| Ingraham LM et al. | In vitro and in vivo effects of treatment by platelet-activating factor on N-formyl-met-leu-phe-mediated responses of polymorphonuclear leucocytes. | 1987 | Br. J. Haematol. | pmid:3038160 |
| Pfueller SL and David R | Different platelet specificities of heparin-dependent platelet aggregating factors in heparin-associated immune thrombocytopenia. | 1986 | Br. J. Haematol. | pmid:3756098 |
| Keraly CL and Benveniste J | Specific desensitization of rabbit platelets by platelet-activating factor (PAF-acether) and derivatives. | 1982 | Br. J. Haematol. | pmid:7082588 |
| Aglietta M et al. | In vivo priming of human normal neutrophils by granulocyte-macrophage colony stimulating factor: effect on the production of platelet activating factor. | 1990 | Br. J. Haematol. | pmid:2201401 |
| Hirayama F | Current understanding of allergic transfusion reactions: incidence, pathogenesis, laboratory tests, prevention and treatment. | 2013 | Br. J. Haematol. | pmid:23215650 |
| Coëffier E et al. | Transient activation of the acetyltransferase necessary for paf-acether biosynthesis in thrombin-activated platelets. | 1986 | Br. J. Haematol. | pmid:3964558 |
| Renesto P et al. | Combined activation of platelets by cathepsin G and platelet activating factor, two neutrophil-derived agonists. | 1992 | Br. J. Haematol. | pmid:1550778 |
| Keraly CL et al. | Effect of structural analogues of PAF-acether on platelet desensitization. | 1983 | Br. J. Haematol. | pmid:6824590 |
| Kaplan R et al. | Combined defect in membrane expression and activation of platelet GPIIb--IIIa complex without primary sequence abnormalities in myeloproliferative disease. | 2000 | Br. J. Haematol. | pmid:11122160 |
| Chignard M et al. | Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents. | 1980 | Br. J. Haematol. | pmid:6778498 |
| Furlan M et al. | Binding of colloidal gold granules, coated with bovine factor VIII, to human platelet membranes. | 1981 | Br. J. Haematol. | pmid:6786321 |
| Murphy WG et al. | Relationship between platelet aggregating factor and von Willebrand factor in thrombotic thrombocytopenic purpura. | 1987 | Br. J. Haematol. | pmid:3499167 |
| Hatmi M et al. | Carrageenan-induced activation of human platelets is dependent on the phospholipase C pathway. | 1993 | Br. J. Haematol. | pmid:8457475 |
| Teeling JL et al. | Intravenous immunoglobulin preparations induce mild activation of neutrophils in vivo via triggering of macrophages--studies in a rat model. | 2001 | Br. J. Haematol. | pmid:11298603 |
| May GR et al. | The role of nitric oxide as an endogenous regulator of platelet and neutrophil activation within the pulmonary circulation of the rabbit. | 1991 | Br. J. Pharmacol. | pmid:1364849 |
| Filep JG et al. | Dexamethasone-induced gastric mucosal damage in the rat: possible role of platelet-activating factor. | 1992 | Br. J. Pharmacol. | pmid:1324056 |
| Norman KE et al. | Comparison of the reversed passive Arthus and local Shwartzman reactions of rabbit skin: effects of the long-acting PAF antagonist UK-74,505. | 1997 | Br. J. Pharmacol. | pmid:9105704 |
| Kamata K et al. | Endothelium-dependent vasodilator effects of platelet activating factor on rat resistance vessels. | 1989 | Br. J. Pharmacol. | pmid:2611496 |
| Pinto A et al. | Castor oil increases intestinal formation of platelet-activating factor and acid phosphatase release in the rat. | 1989 | Br. J. Pharmacol. | pmid:2743081 |
| Flores NA and Sheridan DJ | Electrophysiological and arrhythmogenic effects of platelet activating factor during normal perfusion, myocardial ischaemia and reperfusion in the guinea-pig. | 1990 | Br. J. Pharmacol. | pmid:2076489 |
| Bkaily G et al. | PAF activation of a voltage-gated R-type Ca2+ channel in human and canine aortic endothelial cells. | 1993 | Br. J. Pharmacol. | pmid:8242226 |
| Rogers DF et al. | Bradykinin-induced plasma exudation in guinea-pig airways: involvement of platelet activating factor. | 1990 | Br. J. Pharmacol. | pmid:2076490 |
| Hu W et al. | Partial agonist effect of the platelet-activating factor receptor antagonists, WEB 2086 and WEB 2170, in the rat perfused heart. | 1993 | Br. J. Pharmacol. | pmid:8242237 |